Delcath Posts 17-Cent Q3 EPS as Profitability Takes Hold
DCTH sits 84% above its 52-week low of $8.12.
Summary
Delcath reported third-quarter EPS of 17 cents, a profit figure that follows Q2 net income of $2.7M on revenue of $29.1M that beat estimates by 11%. Third-quarter revenue came in at $35.1M. The company had already raised full-year 2026 revenue guidance to $104M-$108M and held $95.9M in cash and investments, so continued profitability is the key confirmation for a small-cap that only recently turned the corner. Rosalind Advisors' 9.9% blocked stake remains the notable ownership overhang.
At the time of this announcement, DCTH was trading at $14.94 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $518.1M. The 52-week trading range was $8.12 to $17.42. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.